11 June 2020 in Acta Cytologica
Background: Metastases to axillary lymph nodes are commonly and readily confirmed by fine needle aspiration cytology (FNAC). Most likely, these arise from breast primaries. However, the diagnosis can become complicated when unusual cytomorphology is encountered. Case: We report a 60-year-old woman presenting with bilateral axillary lymphadenopathies but without breast lesions. History showed increasing CA-125 levels. FNAC yielded carcinoma cells showing prominent papillary pattern, being composed of mild to moderately differentiated malignant cells, with focal abortive glandular formation and squamous metaplasia. IHC stains were done and the tumor cells were PAX-8 positive, but GATA-3 and GCDFP-15 negative. Coupled with the clinical history, a diagnosis of metastatic endometrioid adenocarcinoma was made. Conclusion: Nodal metastases with papillary cytomorphology can rarely arise from nonbreast primaries. The presence of papillary pattern, particularly in the absence of a clinically detectable breast lesion, should raise the possibility of a metastasis. Correlation with patient history, imaging findings and judicious use of IHC studies are crucial for a correct diagnosis.
29 March 2026 in Histopathology
Aims: De‐escalated treatment for ductal carcinoma in situ (DCIS) aims to prevent overtreatment of patients. However, patients diagnosed preoperatively with pure DCIS via core needle biopsy (CNB) may be upgraded to invasive cancer upon excision. Therefore, it is essential to stratify patients at low risk for upgrade to invasive disease during the biopsy to inform management decisions. Methods and results: In this study, we reviewed a cohort of patients with pure DCIS diagnosed by CNB and their corresponding excision specimens to identify predictive features for upgrading to microinvasion or invasive breast cancer (IBC). Of the 228 CNB cases, 82 (36%) were upgraded at excision, with 26.8% classified as microinvasion and 73.2% as frank invasion. Significant tumour intrinsic features associated with DCIS upgrade included larger tumour size, palpable mass, high grade and presence of necrosis ( P ≤ 0.026). Factors related to sampling adequacy, such as the number of cores, total core length and length of the longest core, were also predictive features ( P ≤ 0.027). Additionally, tumour microenvironment (TME) characteristics, including calcification and stromal tumour‐infiltrating lymphocytes (sTIL), were linked to upgrades, particularly in the human epidermal growth factor 2 (HER2)‐negative subgroup ( P ≤ 0.004). These features were independently associated with frank invasion in HER2‐negative cancers. Conclusions: Our results provide valuable insights into additional predictive features for DCIS upgrade. When combined with adequate sampling and intrinsic tumour characteristics, TME features—namely tumour infiltrating lymphocytes (TILs) and calcification—are useful in predicting DCIS upgrades, especially in HER2‐negative cases.
9 October 2026 in Histopathology
Introduction: The presence of non‐progressing ductal carcinoma in situ (DCIS) cases has raised concerns of overtreatment, necessitating comprehensive risk prediction. The tumour microenvironment, especially cancer‐associated fibroblasts (CAFs), plays a key role in DCIS progression. Fibroblast activation protein alpha (FAP), a CAF biomarker, has shown prognostic potential, but its clinical significance and spatial organization in DCIS remain rarely discussed. Methods: In this study, we employed a digital pathology pipeline to quantify stromal FAP expression and map its spatial organization. A total of 102 breast excision specimens were analysed, including pure DCIS and DCIS with co‐existing invasive carcinoma (either nearby or distant). FAP expression was quantified and correlated with clinicopathological features and survival outcomes. Results: Our results showed that FAP expression was significantly higher in DCIS with nearby invasion compared to DCIS with distant invasion ( P = 0.014) and pure DCIS ( P = 0.006), reaching levels comparable to the invasive component itself. Within these high‐FAP regions, no expression gradient from the invasive front was observed. In multivariable analysis, high FAP expression ( P = 0.053) and nuclear grade ( P = 0.043) were associated with invasion in older patients (≥50 years). Additionally, high FAP expression correlated with high nuclear grade ( P = 0.008), papillary DCIS ( P = 0.029) and HER2‐enriched subtype ( P = 0.0497). Although FAP was not an independent predictor of overall survival, it showed a trend towards poorer survival when combined with invasion. Conclusions: In conclusion, FAP is a promising biomarker for predicting nearby invasive carcinoma. Its integration into the existing risk stratification models could enhance clinically meaningful prediction.